Most recently, ImmunoGenesis raised $44.4M in its Early Stage VC (Mar 2024).
- ·The complete investor list: 13 names
- ·Watch ImmunoGenesis: the Monday email on marks, rounds and moves
ImmunoGenesis round by round
1 roundsHow much has ImmunoGenesis raised?
ImmunoGenesis has raised $67.2 million in total; 1 of its rounds is on record. The largest on record was a $44.4 million early-stage round in Mar 2024.
ImmunoGenesis has filed 1 Form D with the SEC, most recently in Apr 2024 ($44.4 million sold to 88 investors).
ImmunoGenesis investors
13 investors are on record for ImmunoGenesis, including Service Provider Capital, ADIT Ventures, Magnetar Capital and PEAK6 Strategic Capital. By type, the record holds 4 venture capital firms, 2 family offices and 1 hedge fund. The early-stage round in Mar 2024 drew 88 investors.
13 investors have backed ImmunoGenesis.
Frequently asked about ImmunoGenesis
- How much has ImmunoGenesis raised?
- ImmunoGenesis has raised $67.2M in total across 1 recorded funding rounds.
- When was ImmunoGenesis's last funding round?
- ImmunoGenesis's most recent recorded round was Early Stage VC in Mar 2024, raising $44.4M.